115 related articles for article (PubMed ID: 19504000)
1. Chemoprevention by celecoxib in reflux-induced gastric adenocarcinoma in Wistar rats that underwent gastrojejunostomy.
Rocha FT; Lourenço LG; Jucá MJ; Costa V; Leal AT
Acta Cir Bras; 2009; 24(3):189-94. PubMed ID: 19504000
[TBL] [Abstract][Full Text] [Related]
2. Late administration of a specific COX-2 inhibitor does not treat and/or prevent progression of gastric tumors in rats submitted to duodenogastric reflux procedure.
Rodrigues PA; Naresse LE; Rodrigues MA; Kobayasi S
Acta Cir Bras; 2013 Jun; 28(6):453-7. PubMed ID: 23743684
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
4. [An experimental study on chemoprevention of esophageal adenocarcinoma by celecoxib, a selective cyclooxygenase-2 inhibitor].
Zhang T; Su LW; Zhu YF; Lang HJ; Zhang F; Zhou YA; Liang XH; Wang YJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 May; 15(5):512-6. PubMed ID: 22648851
[TBL] [Abstract][Full Text] [Related]
5. [A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats].
Miwa K; Oyama K; Fujimura T
Nihon Rinsho; 2005 Aug; 63(8):1387-93. PubMed ID: 16101227
[TBL] [Abstract][Full Text] [Related]
6. Gastric proliferative lesions induced by duodenogastric reflux in rats.
Monteiro RL; Andreollo NA; Rodrigues MA; Araujo MR
Acta Cir Bras; 2006; 21(4):207-13. PubMed ID: 16862339
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of gastric cancer by celecoxib in rats.
Hu PJ; Yu J; Zeng ZR; Leung WK; Lin HL; Tang BD; Bai AH; Sung JJ
Gut; 2004 Feb; 53(2):195-200. PubMed ID: 14724149
[TBL] [Abstract][Full Text] [Related]
8. Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: implications on chemoprevention.
Yu J; Tang BD; Leung WK; To KF; Bai AH; Zeng ZR; Ma PK; Go MY; Hu PJ; Sung JJ
World J Gastroenterol; 2005 Jan; 11(1):41-5. PubMed ID: 15609394
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of adenocarcinoma induced by gastrojejunostomy in Wistar rats: role of duodenogastric reflux.
Kondo K; Kojima H; Akiyama S; Ito K; Takagi H
Carcinogenesis; 1995 Aug; 16(8):1747-51. PubMed ID: 7634399
[TBL] [Abstract][Full Text] [Related]
10. Does troncular vagotomy modify the proliferative gastric lesions induced in rats by duodenogastric reflux?
Rodrigues PA; Kobayasi S; Rodrigues MA
Acta Cir Bras; 2007; 22(3):210-4. PubMed ID: 17546294
[TBL] [Abstract][Full Text] [Related]
11. Short-term celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model.
Kuo CH; Hu HM; Tsai PY; Wu IC; Yang SF; Chang LL; Wang JY; Jan CM; Wang WM; Wu DC
World J Gastroenterol; 2009 Oct; 15(39):4907-14. PubMed ID: 19842220
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of glandular stomach carcinogenesis through duodenogastric reflux in rats by a COX-2 inhibitor.
Oba M; Miwa K; Fujimura T; Harada S; Sasaki S; Hattori T
Int J Cancer; 2008 Oct; 123(7):1491-8. PubMed ID: 18646190
[TBL] [Abstract][Full Text] [Related]
13. [The influence of reflux of bile and pancreatic juice on gastric carcinogenesis in rats].
Kojima H; Kondo K; Takagi H
Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):818-26. PubMed ID: 2398876
[TBL] [Abstract][Full Text] [Related]
14. [Duodenogastric reflux and gastric carcinogenesis in rats].
Hasegawa H
Nihon Shokakibyo Gakkai Zasshi; 1991 Aug; 88(8):1517-24. PubMed ID: 1942605
[TBL] [Abstract][Full Text] [Related]
15. [Cyclooxygenase (COX)-2 expression in a rat duodenoesophageal reflux model and chemoprevention of adenocarcinoma by the selective COX-2 inhibitor nimesulide].
Oyama K; Fujimura T; Ninomiya I; Miyashita T; Kinami S; Fushida S; Ohta T
Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1183-91. PubMed ID: 17675820
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole and adenocarcinoma in the stomach of rats submitted to duodenogastric reflux. Is there a protective effect?
Monteiro RLR; Kobayasi MAMR; Araujo MR; Monteiro DR; Andreollo NA
Acta Cir Bras; 2020; 35(9):e202000904. PubMed ID: 33027361
[TBL] [Abstract][Full Text] [Related]
17. The role of duodenogastric reflux in formation of precarcinogenic gastric lesions--an experimental study.
Zlatić A; Stojanović M; Mihailović D; Dinić BR; Protić M; Veljković R
Med Pregl; 2013; 66(7-8):285-91. PubMed ID: 24069809
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
19. Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin histochemistry, polyamine metabolism, and labelling index.
Taylor PR; Mason RC; Filipe MI; Vaja S; Hanley DC; Murphy GM; Dowling RH; McColl I
Gut; 1991 Dec; 32(12):1447-54. PubMed ID: 1773947
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclooxygenase-2 causes regression of gastric adenomas in trefoil factor 1 deficient mice.
Thiel A; Narko K; Heinonen M; Hemmes A; Tomasetto C; Rio MC; Haglund C; Mäkelä TP; Ristimäki A
Int J Cancer; 2012 Sep; 131(5):1032-41. PubMed ID: 22034055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
